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ABSTRACT 
Role of the N-terminus of Rpb9 in RNA Polymerase II Transcription 
Katherine Nguyen 
Department of Biochemistry and Biophysics 
Texas A&M University 
Research Advisor: Dr. David Peterson 
Department of Biochemistry and Biophysics 
Eukaryotic transcription is a highly regulated process that requires RNA polymerase to 
continuously proofread and edit the RNA stand before it continues to elongate. A subunit in RNA 
polymerase II (RNAPII), known as Rpb9, plays an important role in the efficiency of RNA 
proofreading and maintains the health of a cell as a whole. Recent studies have proven that Rpb9 
serves at least two functions, one of which resides in the C-terminal half of the protein and the 
other in the N-terminal half.  The experiments proposed here suggest a genetic approach to start 
to determine the function of the N-terminal domain. 
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CHAPTER I  
INTRODUCTION 
Transcripts produced in eukaryotic cells are constantly being proofread by RNA polymerase II 
during transcriptional elongation. One small subunit of RNAPII, Rpb9, a protein composed of 
122 amino acids, has been proven to have a significant role in the proofreading activity of the 
polymerase. Recent research has shown that in the absence of Rpb9, errors incurred during 
transcription are not efficiently corrected. Incorrect matches to the template DNA strand are 
normally cleaved by an accessory factor called TFIIS, which associates with the polymerase and 
reprograms the active site for the removal of misincorporated nucleotides (1). Rpb9 has been 
proven to be crucial in slowing the elongation process after a misincorporation, providing a 
checkpoint during which the polymerase can backtrack and proofread the transcript (1). 
Therefore, the absence of Rpb9 causes errors in the transcript to be extended at a faster rate, 
restricting the time frame of that checkpoint (1). Not only does Rpb9 play a crucial role in TFIIS-
mediated cleavage, it also affects mismatch extension (2). Random mutations caused by the 
decreased proofreading activity of the polymerase affects the overall health and growth of the 
cell (3).  
Furthermore, recent studies have suggested that not only do the errors incurred during 
transcription impede normal cellular health but also have the potential to inflict human diseases 
related to abnormal protein folding, such as Alzheimer’s disease (4). Proteins that are translated 
from erroneous mRNA strands sometimes do not have the correct three-dimensional structure 
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(4).  In fact, some of the mutated proteins are not able to fold at all, and can cause increased 
levels of proteotoxic stress (4). Experimental evidence has also shown that the number of errors 
made during transcription is directly related to cell age (4). Therefore, it is possible that the 
accumulation of transcription errors made and propagated by an error-prone polymerase can be a 
new mechanism by which some human diseases are developed.   
The structure of Rpb9 consists of two domains. The C-terminal domain of the protein has proven 
to be significant in reducing the number of errors present in the mRNA strand. Experiments have 
shown that cells containing certain mutations on the C-terminal domain of Rpb9 exhibit the same 
increased speed in error propagation as cells lacking the entire Rpb9 protein (5).  There is 
convincing evidence that the N-terminal domain of Rpb9 serves a function independent from the 
C-terminal domain. The majority of the growth defects present in Rpb9-deficient cells can be 
rescued by a truncated Rpb9 containing only the first 59 amino acids of the protein.  The N-
terminal domain of Rpb9 has also been proposed to affect transcription start-site selection. 
The experiments described here are part of a larger genetic and biochemical study to explicitly 
define the role of the N-terminal domain of Rpb9 on RNAPII activity and the interactions of 
RNAPII with other components of the eukaryotic transcription machinery. Saccharomyces 
cerevisiae (S. cerevisiae), more commonly known as Baker’s yeast, was used as the model 
organism in these experiments, as it is a simple organism that possesses eukaryotic transcription 
machinery. We are interested in identifying the specific amino acids within the N-terminal 
domain of Rpb9 that, if changed, have visible effects on how a eukaryotic cell grows in various 
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environments. In order to accomplish this, an array of random mutations in the N-terminal 
domain of Rpb9 will be created and then screened for phenotypes associated with an rpb9 
deletion. The goal is to find a particular amino acid sequence present on the N-terminal domain 
of Rpb9 that, if mutated, will cause cells to mimic the growth patterns of cells missing the entire 
RPB9 gene. Sequencing the mutations found in the selected alleles will identify amino acids that 
are critical for the function of the N-terminal domain of Rpb9 and will allow for the development 
of specific hypotheses related to their effect on RNAPII. The work described here is a part of 
efforts to develop a sensitive screen to more efficiently identify mutations in the N-terminal 






Mutants generated from random mutagenesis, Rpb9(4-6)X mutants, that showed stunted or 
abnormal growth were single colony purified for further testing. Colony PCR (cPCR) was 
performed in order to amplify the mutant DNA. During colony PCR, fresh yeast cells were 
placed into 10 µL of 0.02 N NaOH. A layer was paraffin oil was added to the sample to prevent 
evaporation in the subsequent heating process. The heat and sodium hydroxide function to lyse 
the yeast cells and release both RNA and DNA molecules. Water was then added to each sample 
of lysed cells to make a 1:5 diluted DNA sample. A master mix containing Taq polymerase, 10x 
PCR buffer, water, 0.2 mM dNTP’s, 0.2 mM of T3 primer, and 0.2 mM of T7 primer was then 
added to each of the samples. Each sample contained 10 µL of the diluted sample, 31 µL of 
dH2O, 5 µL of buffer, and 1 µL of each primer, dNTP’s, and polymerase. The genetic sequence of 
each mutant was amplified using the Polymerase Chain Reaction. For colony PCR, the PCR 
machine ran for 1 minute at 94ºC. The PCR continued to cycle 40 times, with each cycle 
consisting of 30 seconds at 95ºC, then 30 seconds at 45ºC, and finally 2.5 minutes at 72ºC. At the 
end of the reaction, the samples were held at 10ºC. About 5 µL of the PCR products were 
removed from the tube. This portion of product was saved to confirm the efficiency of the PCR 




Gel electrophoresis was used to determine if the mutants contained the RPB9 construct and if 
purification was successful. About 5 µL of the sample not cleaned using the Qiagen PCR 
Cleanup Kit was mixed in with 1 µL of 6X dye. The resulting solution was loaded into a 0.8% 
agarose gel. One µL of 50% glycerol and 1 µL of 6X dye were added to 5 µL of the purified 
samples. The entire solution of pure sample, glycerol, and dye were loaded into a well. The 
agarose gel contained GelRed, which was used as an intercalating agent. The gel was allowed to 
run at 80 V in 1X TAE buffer and was analyzed under UV light. A band was present around the 
1200 bp region, indicating the presence of rpb9 on the transformed plasmid.  
Amplification PCR 
The purified products were amplified a second time using Amplification PCR (aPCR). To each 
PCR tube, 2 µL of the sample cleaned by the Qiagen PCR Cleanup Kit, 39 µL of dH2O, 5 µL of 
10X PCR buffer, 1 µL of Taq polymerase, 1 µL of 10 mM T3 primer, 1 µL of 10mM T7 primer, 
and 1 µL of 10 mM dNTP’s were added. All tubes were placed into the thermocycler and ran 
under the same PCR program as cPCR. The products yielded by aPCR were cleaned a second 
time using the Qiagen PCR Cleanup Kit. 
Concentration measurement 
 The concentrations of the resulting samples were measured using BioTek’s Epoch Micro-
Volume Spectrophotometer System. Only samples containing more than 100 ng/µL of DNA 
qualified for sequencing.  
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Sequencing PCR 
Two µL of each of the doubly purified samples, 1 µL of water, 1 µL of Big Dye, and 1 µL of T3 
primer were added into clean test tubes. Sequencing PCR was then used to amplify the purified 
sample solutions. At the beginning of this process, the PCR machine ran for 4 minutes at 96ºC. 
This allows for the initial denaturation of the DNA strands. The PCR continued to cycle 30 
times, with each cycle consisting of 30 seconds at 96ºC, then 15 seconds at 50ºC, and finally 4 
minutes at 60ºC. At the end of the reaction, the samples are held at 10ºC. 
DNA sequencing 
In preparation for DNA sequencing, the samples were placed into size-exclusion gel columns. 
Before the addition of the sample, however, the gel columns were centrifuged at 1000 g for 2 
minutes. The buffer supernatant was then disposed and the column was placed into another tube. 
Water was added to each sample to make a total volume of 50 µL, and then all of the diluted 
sample was dispensed through the gel column. After centrifugation at 1000 g for 4 minutes, the 
tubes were dried for an hour using a RoboVap spinning apparatus. The dehydrated products and 
sequences were then sent to the Texas A&M Gene Technology Lab in the Biology Department 
for analysis. The gene technology lab ran an automated sequencing procedure that generated the 
sequence of DNA. By sequencing the Rpb9 mutants, we sought to identify the amino acid 
sequence located in the N-terminal domain that is crucial in maintaining the function of the Rpb9 
protein.  
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Transformation using yeast construct  
Yeast cells with a rpb9∆::NATMX4 imd2∆::HIS3 genome were transformed with trialanine 
mutant plasmids. One thousand µL of the transformed cultures were centrifuged and resuspended 
in 800 µL of transformation solution. The transformation mix consisted of 700 µL of Magic Mix 
(0.2 M lithium acetate, 40% polyethylene glycol 3350), 72 µL of dH2O, 8 µL of 1 M DTT, and 
20 µL of 2 mg/mL single-strand salmon sperm DNA. All transformations were grown on -leu 
plates.  
Replica plating  
Transformed cells were replica plated onto -leu, -leu -his, -leu with 0.04 µg/mL of MPA, -leu -his 
with 0.04 µg/mL of MPA, -leu -his with 0.04 µg/mL of MPA and 5 mM of 3AT (3-amino-
triazole), and -leu -his with 0.04 µg/mL of MPA and 10 mM of 3AT. All plates were grown at 




Site-directed trialanine mutagenesis 
A library of mutations that introduced amino acid substitutions into the N-terminal domain of 
Rpb9 has already been made using site-directed mutagenesis. These mutations were generated on 
a plasmid of Escherichia coli (E.coli) using primers to introduce changes in the DNA that caused 
three consecutive amino acids in Rpb9 to be replaced with alanine. The growth patterns of the 
trialanine mutants were then assessed, and colonies that exhibited similar growth to Rpb9-
deficient cells were selected for further study.  Yeast cells that contained the trialanine mutation 
at the 4-6 amino acid position yielded a promising phenotype. The mutations were made 
according to Figure 1. 
 
Figure 1. Rpb9(C-flag) N-terminal Domain Amino Acid Changes: Mutations generated through 
site-directed trialanine mutagenesis  
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Random mutagenesis 
Targeted yet random mutations were then constructed in wild-type yeast cells at the 4-6 residue 
position of RPB9. Each construct contained three different mutant amino acid sequences at the 
4-6 position and were made using PCR-mediated mutagenesis. Multiple assays were carried out 
in order to phenotype the newly created Rpb9 mutant yeast colonies, denoted as Rpb9(4-6)X 
mutants. In one experiment, the Rpb9(4-6)X cells were plated onto mycophenolic acid (MPA) 
and their growth patterns were accessed as the drug concentration increased. MPA inhibits the 
production of GTP, which results in stunted growth of hypersensitive yeast cells. Some cells, 
however, have the ability to induce the production of inosine monophosphate dehydrogenase 2 
(IMD2), an enzyme used to overcome the deficiency of GTP caused by the presence of MPA. 
Interestingly, the induced transcription of IMD2 is correlated with the speed at which RNA 
polymerase initiates and elongates transcription. Therefore, growth patterns on MPA plates 
provides information about the speed of the polymerases present in the generated mutants.  
Preliminary results suggest that some rpb9 mutants had higher levels of sensitivity for the drug 
and were selected for further study. In another experiment, the mutant yeast cells were grown in 
an environment of 37°C. Some candidates were more sensitive to higher temperatures and did 
not grow as well as the wild-type yeast cells. These results indicated that certain amino acids 




There is a single amino acid change in the N-terminus of Rpb9, specifically in the 4-6 nucleotide 
region, that can significantly affect the growth of yeast cells in various stress conditions. Yeast 
cells that contained the T3S variant of the Rpb9 protein were more sensitive to mycophenolic 
acid than their wild-type counterparts.  The significant amino acid change was specifically 
caused by two nucleotide changes. Nucleotide 8, usually containing C, was changed to a G. 
Secondly, nucleotide 9 was changed from a G to a C. By obtaining the specific amino acid 
changes that are critical for the function of the N-terminal domain of Rpb9, we can start to 
develop specific hypotheses related to their effect on RNAPII and eukaryotic transcription. 
Replica plating 
After 72 hours of growth, the -leu -his plate containing 0.04 µg/mL of MPA and 5 mM of 3AT 
showed the best gradation in cellular growth. The IMD2 gene contains two transcription sites, 
but only the downstream transcription site produces a functional protein. The IMD2 open reading 
frame was replaced with the HIS3 open reading frame to provide a much more sensitive assay for 
the induction of transcription from the IMD2 promoter. MPA is a drug that induces the selection 
of the downstream transcription start-site in the presence of Rpb9. Without the proper function of 
Rpb9, MPA fails to induce the selection of the downstream transcription start-site. This should 
result in the stunted growth of Rpb9 mutants in the presence of MPA. Addition of 3AT, an 
inhibitor of the HIS3 gene product, can be used to adjust the sensitivity of the assay.  
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Figure 2. New Method Allows for More Sensitive Screening of Rpb9 mutants:  All plates 
pictured are after 72 hours of growth. Plates 1-3 show normal growth patterns for all yeast 
strains. Plate 4 demonstrates stunted growth patterns for N-terminal rpb9 mutants and essentially 
no growth for rpb9∆ mutants. MPA or mycophenolic acid induces IMD2 expression, and 3-




Using the rpb9∆::NATMX4 imd2∆::HIS3 yeast strain, a more sensitive method was generated for 
screening Rpb9 N-terminal mutants. By replacing the IMD2 open reading frame with the HIS3 
open reading frame, the transcription start-site defects could be phenotypically observed. The 
replacement of the genomic, wild-type RPB9 gene with NATMX4, a gene that encodes an 
enzyme that inactivates the antibiotic nourseothricin, allowed for the knockout of genomic RPB9 
to be phenotypically verified.  Plasmids containing mutant rpb9 genes were used to introduce 
different alleles of rpb9 into the yeast cells. These plasmids enabled the determination of whether 
the different alleles affect the ability of the yeast cells to induce transcription from the IMD2 
promoter, which, in this strain, results in expression of HIS3. The addition of MPA induces 
transcription start-site selection. The addition of 3AT, an inhibitor of the HIS3 gene product, can 
be used to fine tune how much HIS3 needs to be expressed to allow the cells to grow in the 
absence of added histidine. This inhibitory protein can be used to adjust the sensitivity of the 
assay. 
This new method of mutant screening will allow for the identification of the most important 
residues on the N-terminus of Rpb9. More site-specific mutants can be generated to identify 
specific alleles that significantly affect Rpb9 function. This study can also be expanded to 
investigate associations between start-site selection and other functions of Rpb9. 
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